Highbridge Capital Management LLC cut its stake in shares of Agilent Technologies Inc (NYSE:A) by 87.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,300 shares of the medical research company’s stock after selling 150,505 shares during the quarter. Highbridge Capital Management LLC’s holdings in Agilent Technologies were worth $1,503,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of A. SRS Capital Advisors Inc. boosted its stake in Agilent Technologies by 75.9% during the second quarter. SRS Capital Advisors Inc. now owns 1,791 shares of the medical research company’s stock worth $110,000 after acquiring an additional 773 shares in the last quarter. Moneta Group Investment Advisors LLC boosted its stake in Agilent Technologies by 391.7% during the second quarter. Moneta Group Investment Advisors LLC now owns 6,023 shares of the medical research company’s stock worth $158,000 after acquiring an additional 4,798 shares in the last quarter. TRUE Private Wealth Advisors bought a new position in Agilent Technologies during the third quarter worth $181,000. AMG National Trust Bank bought a new position in Agilent Technologies during the third quarter worth $212,000. Finally, UMB Bank N A MO bought a new position in Agilent Technologies during the third quarter worth $219,000.

Several research analysts recently issued reports on A shares. Morgan Stanley increased their target price on shares of Agilent Technologies from $83.00 to $84.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 15th. Deutsche Bank raised their price objective on shares of Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, August 15th. ValuEngine lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, August 18th. Goldman Sachs Group raised shares of Agilent Technologies from a “buy” rating to a “conviction-buy” rating in a research note on Monday, September 17th. Finally, Zacks Investment Research lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday, October 16th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $78.75.

Agilent Technologies stock opened at $70.25 on Friday. Agilent Technologies Inc has a 1-year low of $60.42 and a 1-year high of $75.11. The firm has a market capitalization of $22.92 billion, a price-to-earnings ratio of 25.77, a price-to-earnings-growth ratio of 2.01 and a beta of 1.36. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.74 and a current ratio of 3.29.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 19th. The medical research company reported $0.81 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.07. Agilent Technologies had a net margin of 6.43% and a return on equity of 19.84%. The firm had revenue of $1.29 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same period last year, the firm earned $0.67 earnings per share. The business’s quarterly revenue was up 8.8% compared to the same quarter last year. Equities research analysts predict that Agilent Technologies Inc will post 3.04 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 23rd. Shareholders of record on Monday, December 31st will be paid a $0.164 dividend. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.93%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.15. The ex-dividend date is Friday, December 28th. Agilent Technologies’s dividend payout ratio (DPR) is 21.51%.

Agilent Technologies announced that its Board of Directors has approved a stock buyback plan on Monday, November 19th that permits the company to repurchase $1.75 billion in shares. This repurchase authorization permits the medical research company to buy up to 8.8% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board of directors believes its stock is undervalued.

In other news, CEO Michael R. Mcmullen sold 15,923 shares of the stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $73.20, for a total value of $1,165,563.60. Following the completion of the sale, the chief executive officer now owns 492,546 shares in the company, valued at $36,054,367.20. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Rodney Gonsalves sold 1,500 shares of the stock in a transaction dated Wednesday, November 28th. The shares were sold at an average price of $71.06, for a total transaction of $106,590.00. The disclosure for this sale can be found here. Insiders sold 34,683 shares of company stock worth $2,499,491 over the last ninety days.

WARNING: “Agilent Technologies Inc (A) Shares Sold by Highbridge Capital Management LLC” was originally posted by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.watchlistnews.com/agilent-technologies-inc-a-shares-sold-by-highbridge-capital-management-llc/2669950.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: What does relative strength index mean?

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.